Implantable cardioverter defibrillator in arrhythmogenic cardiomyopathy: which role for antitachycardia pacing?

3 April 2022 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Alberto Spadotto

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

6 More presentations in this session

Presentation thumbnail

Anatomically-guided cardioneuroablation for recurrent neurally mediated syncope

Associate Professor D. Wichterle (Prague, CZ)

Abstract Slides

Presentation thumbnail

QRS duration as an independent risk factor for appropriate shocks and mortality in patients with prophylactic implantable cardioverter-defibrillator

Doctor P. Bengel (Giessen, DE)

Abstract Slides

Presentation thumbnail

Threshold values by electrocardiogram and echocardiography indicating transition to an arrhythmic phenotype in cardiac laminopathies: a primary prevention cohort study

Doctor C. Rootwelt-Norberg (Oslo, NO)

Abstract Slides

Presentation thumbnail

Virtual induction and treatment of arrhythmias (VITA): a fast automated computational tool to induce scar-related tachycardia and identify ablation targets

Doctor F. Campos (London, GB)

Abstract Slides

Presentation thumbnail

Neuronal nitric oxide synthase inhibition exacerbates atrial electrical remodeling via small-conductance Ca2+-activated K+ channel activation

Doctor T. Koya (Sapporo, JP)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters - Basic science and a variety of arrhythmias

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

You may be interested in

Congress Session

Ventricular storm (2)

Congress Presentation

When to consider device therapy in HFrEF - discussion

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources